Drug Type Chemical drugs |
Synonyms GX 936 |
Target |
Action modulators |
Mechanism Nav1.7 modulators(Sodium channel protein type IX alpha subunit modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC24H20F3N7O3S2 |
InChIKeyUCAVSLIXTXZSRD-UHFFFAOYSA-N |
CAS Registry1235406-09-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | United States | 17 Dec 2015 | |
Pain | Preclinical | Canada | 17 Dec 2015 |